Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fletcher

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Oncology|July 4, 2019
Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity MapChueh-Chuan Yen, Li-Tzong Chen, Chien-Feng Li, et al.
Genes, Chromosomes & Cancer|January 17, 2016
ALK-rearranged renal cell carcinomas in childrenMariana M Cajaiba, Lawrence J Jennings, Stephen M Rohan, et al.
The Journal of Pathology|February 2, 2012
Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidneyElaine O'Meara, Deirdre Stack, Cheng-Han Lee, et al.
The American Journal of Surgical Pathology|December 5, 2017
BCOR Internal Tandem Duplication in High-grade Uterine SarcomasAdrián Mariño-Enriquez, Alexandra Lauria, Joanna Przybyl, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2003
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocationIan J Davis, Bae-Li Hsi, Jason D Arroyo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumorsSeppo Parkkila, Jerzy Lasota, Jonathan A Fletcher, et al.
Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.
Cancer Science|August 25, 2018
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumorHui-Jen Tsai, Weir-Torn Jiaang, Neng-Yao Shih, et al.
Oncotarget|October 6, 2016
Targeting SALL4 by entinostat in lung cancerKol Jia Yong, Ailing Li, Wen-Bin Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Oncology|July 4, 2019
Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity MapChueh-Chuan Yen, Li-Tzong Chen, Chien-Feng Li, et al.
Genes, Chromosomes & Cancer|January 17, 2016
ALK-rearranged renal cell carcinomas in childrenMariana M Cajaiba, Lawrence J Jennings, Stephen M Rohan, et al.
The Journal of Pathology|February 2, 2012
Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidneyElaine O'Meara, Deirdre Stack, Cheng-Han Lee, et al.
The American Journal of Surgical Pathology|December 5, 2017
BCOR Internal Tandem Duplication in High-grade Uterine SarcomasAdrián Mariño-Enriquez, Alexandra Lauria, Joanna Przybyl, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2003
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocationIan J Davis, Bae-Li Hsi, Jason D Arroyo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumorsSeppo Parkkila, Jerzy Lasota, Jonathan A Fletcher, et al.
Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.
Cancer Science|August 25, 2018
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumorHui-Jen Tsai, Weir-Torn Jiaang, Neng-Yao Shih, et al.
Oncotarget|October 6, 2016
Targeting SALL4 by entinostat in lung cancerKol Jia Yong, Ailing Li, Wen-Bin Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.
Pageof 21